May 25, 2021 / 12:00PM GMT
Matthew Charles Taylor - UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices
Good morning, and welcome to day 2 of the UBS Global Healthcare Conference. This is the medtech track, and I'm Matt Taylor, UBS' U.S. medical supplies and devices analyst. And for this session, we're going to be joined by management from LivaNova.
Just a couple of words about the session. It's going to be about a 45-minute fireside chat, and I have a lot of questions ready and prepared. But if you want to send some in for us to weave into the conversation, you can e-mail me at [email protected] or use the webcast tool to submit a question, and we'll take that into the conversation.
So first, I just want to welcome both Damien McDonald, the CEO of LivaNova; and Matt Dodds, who's Senior Vice President of Corporate Development. Thanks a lot, guys, for making the time and for being here today.
Damien McDonald - LivaNova PLC - CEO & Director
You're welcome, Matt. And thanks for hosting us and having us along via
LivaNova PLC at UBS Global Healthcare Virtual Conference Transcript
May 25, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers